Vitrolife AB
STO:VITR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Vitrolife AB (VITR) under the Base Case is SEK per share.
Compared with the current market price of 117.7 SEK, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Vitrolife AB Does
Vitrolife AB makes products and services used in fertility treatment and assisted reproduction. Its main customers are IVF clinics and other fertility specialists, who use the company’s lab equipment, culture media, needles, dishware, and related consumables to handle eggs, sperm, embryos, and genetic testing during treatment. In plain terms, Vitrolife sells the tools and materials clinics need to help patients go through IVF procedures.
- Headquarters
- Sweden SE
- Employees
- 1 126
- IPO date
- Jun 26, 2001
Balance Sheet
Recent Events
Latest Earnings Call
Vitrolife emphasized scaling technology adoption and innovation while directing resources toward profitable markets, against uneven regional IVF demand and persistent softness in China.
What management delivered: 1 worse than forecast
Open the earnings call- EPS
- kr0.94
- Expected
- kr0.93
- Surprise
- +1.1%
- Stock, day of the call
- +5.0%
Past 12 months
Continue VITR Research
Decided on Vitrolife? Get an email when VITR reaches the price you’d buy at. Free with an account.
Other Vitrolife listings
What is the Intrinsic Value of one VITR stock?
The intrinsic value for
Vitrolife AB (VITR) under the Base Case is SEK.
Is VITR stock undervalued or overvalued?
Compared with the current market price of 117.7 SEK, the stock appears .